Header Logo

Connection

Ebrahim Variava to Female

Back to Details
This is a "connection" page, showing publications Ebrahim Variava has written about Female.
Ebrahim Variava
Connection Strength
1,603
Female
  1. Hypertension guideline implementation and blood pressure control in Matlosana, South Africa. S Afr Fam Pract (2004). 2024 10 30; 66(1):e1-e10.
    View in: PubMed
    Score: 0,091
  2. Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrob Agents Chemother. 2024 May 02; 68(5):e0158323.
    View in: PubMed
    Score: 0,088
  3. Brief Report: Changing Characteristics Among In-Hospital HIV Deaths: An 11-Year Retrospective Review of a Regional Hospital in South Africa. J Acquir Immune Defic Syndr. 2023 11 01; 94(3):185-189.
    View in: PubMed
    Score: 0,085
  4. HIV Prevalence and Morbidity in Older Inpatients in a High HIV Prevalence Setting. AIDS Res Hum Retroviruses. 2020 03; 36(3):186-192.
    View in: PubMed
    Score: 0,065
  5. Readmission and death following hospitalization among people with HIV in South Africa. PLoS One. 2019; 14(7):e0218902.
    View in: PubMed
    Score: 0,063
  6. Value stream mapping to characterize value and waste associated with accessing HIV care in South Africa. PLoS One. 2018; 13(7):e0201032.
    View in: PubMed
    Score: 0,059
  7. Brief Report: Late Efavirenz-Induced Ataxia and Encephalopathy: A Case Series. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):577-579.
    View in: PubMed
    Score: 0,055
  8. Development of a respiratory severity score for hospitalized adults in a high HIV-prevalence setting-South Africa, 2010-2011. BMC Pulm Med. 2017 02 02; 17(1):28.
    View in: PubMed
    Score: 0,053
  9. Acute Kidney Injury, Risk Factors, and Prognosis in Hospitalized HIV-Infected Adults in South Africa, Compared by Tenofovir Exposure. AIDS Res Hum Retroviruses. 2017 01; 33(1):33-40.
    View in: PubMed
    Score: 0,052
  10. Tuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South Africa. PLoS One. 2015; 10(2):e0117813.
    View in: PubMed
    Score: 0,047
  11. Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa. Trop Med Int Health. 2013 Jan; 18(1):109-16.
    View in: PubMed
    Score: 0,040
  12. Cohort profile: the potentially preventable burden of community-acquired pneumonia in South African adults in the era of widespread PCV13 immunisation and antiretroviral therapy roll-out, before and during the COVID-19 pandemic - the multicentre, multimethod PotPrev Study. BMJ Open. 2024 12 20; 14(12):e080553.
    View in: PubMed
    Score: 0,023
  13. A randomized trial for combination nicotine replacement therapy for smoking cessation among people with HIV in a low-resourced setting. AIDS. 2025 Apr 01; 39(5):526-534.
    View in: PubMed
    Score: 0,023
  14. Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 - 2018. BMC Infect Dis. 2024 Oct 09; 24(1):1128.
    View in: PubMed
    Score: 0,023
  15. Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa. Int J Epidemiol. 2024 Aug 14; 53(5).
    View in: PubMed
    Score: 0,022
  16. TB diagnoses and mortality in hospitalized people living with HIV in South Africa. Int J Tuberc Lung Dis. 2024 Jun 01; 28(6):301-303.
    View in: PubMed
    Score: 0,022
  17. Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial. Lancet Infect Dis. 2024 Sep; 24(9):1003-1014.
    View in: PubMed
    Score: 0,022
  18. Reducing HIV-Associated Post-Hospital Mortality Through Home-Based Care in South Africa: A Randomized Controlled Trial. Clin Infect Dis. 2024 May 15; 78(5):1256-1263.
    View in: PubMed
    Score: 0,022
  19. D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15?years. Contemp Clin Trials. 2024 Jul; 142:107540.
    View in: PubMed
    Score: 0,022
  20. Undiagnosed Pulmonary Tuberculosis (TB) and Coronavirus Disease 2019 (COVID-19) in Adults Dying at Home in a High-TB-Burden Setting, Before and During Pandemic COVID-19: An Autopsy Study. Clin Infect Dis. 2023 08 14; 77(3):453-459.
    View in: PubMed
    Score: 0,021
  21. Coronavirus Host Genomics Study: South Africa (COVIGen-SA). Glob Health Epidemiol Genom. 2022; 2022:7405349.
    View in: PubMed
    Score: 0,020
  22. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial. Lancet HIV. 2022 09; 9(9):e627-e637.
    View in: PubMed
    Score: 0,019
  23. Key risk factors for substance use among female sex workers in Soweto and Klerksdorp, South Africa: A cross-sectional study. PLoS One. 2022; 17(1):e0261855.
    View in: PubMed
    Score: 0,019
  24. Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children. N Engl J Med. 2021 12 30; 385(27):2531-2543.
    View in: PubMed
    Score: 0,019
  25. ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing. BMC Infect Dis. 2021 Jan 04; 21(1):5.
    View in: PubMed
    Score: 0,018
  26. Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 10 21; 38(45):7007-7014.
    View in: PubMed
    Score: 0,017
  27. Influenza disease burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 06 02; 38(27):4288-4297.
    View in: PubMed
    Score: 0,017
  28. Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: Analysis of baseline data from a cluster-randomised trial. PLoS One. 2020; 15(3):e0230376.
    View in: PubMed
    Score: 0,017
  29. Intensified household contact tracing, prevention and treatment support versus enhanced standard of care for contacts of tuberculosis cases in South Africa: study protocol for a household cluster-randomised trial. BMC Infect Dis. 2019 Oct 12; 19(1):839.
    View in: PubMed
    Score: 0,016
  30. Performance of Surveillance Case Definitions in Detecting Respiratory Syncytial Virus Infection Among Young Children Hospitalized With Severe Respiratory Illness-South Africa, 2009-2014. J Pediatric Infect Dis Soc. 2019 Sep 25; 8(4):325-333.
    View in: PubMed
    Score: 0,016
  31. Quantifying How Different Clinical Presentations, Levels of Severity, and Healthcare Attendance Shape the Burden of Influenza-associated Illness: A Modeling Study From South Africa. Clin Infect Dis. 2019 08 30; 69(6):1036-1048.
    View in: PubMed
    Score: 0,016
  32. Prevalence and Correlates of Snuff Use, and its Association With Tuberculosis, Among Women Living With HIV in South Africa. Nicotine Tob Res. 2019 07 17; 21(8):1087-1092.
    View in: PubMed
    Score: 0,016
  33. Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial. Lancet Respir Med. 2019 03; 7(3):249-259.
    View in: PubMed
    Score: 0,015
  34. High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen. Eur Respir J. 2018 12; 52(6).
    View in: PubMed
    Score: 0,015
  35. Hospitalization and post-discharge care in South Africa: A critical event in the continuum of care. PLoS One. 2018; 13(12):e0208429.
    View in: PubMed
    Score: 0,015
  36. Influenza Viral Shedding in a Prospective Cohort of HIV-Infected and Uninfected Children and Adults in 2 Provinces of South Africa, 2012-2014. J Infect Dis. 2018 09 08; 218(8):1228-1237.
    View in: PubMed
    Score: 0,015
  37. Prevalence and Correlates of Smoking Among People Living With HIV in South Africa. Nicotine Tob Res. 2018 08 14; 20(9):1124-1131.
    View in: PubMed
    Score: 0,015
  38. Healthcare utilization for common infectious disease syndromes in Soweto and Klerksdorp, South Africa. Pan Afr Med J. 2018; 30:271.
    View in: PubMed
    Score: 0,015
  39. Relevance and acceptability of using the Quantiferon gold test (QGIT) to screen CD4 blood draws for latent TB infection among PLHIV in South Africa: formative qualitative research findings from the TEKO trial. BMC Health Serv Res. 2018 04 16; 18(1):288.
    View in: PubMed
    Score: 0,015
  40. Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015. Emerg Infect Dis. 2018 03; 24(3):506-513.
    View in: PubMed
    Score: 0,014
  41. The effects of the attributable fraction and the duration of symptoms on burden estimates of influenza-associated respiratory illnesses in a high HIV prevalence setting, South Africa, 2013-2015. Influenza Other Respir Viruses. 2018 05; 12(3):360-373.
    View in: PubMed
    Score: 0,014
  42. Indoor air pollution from secondhand tobacco smoke, solid fuels, and kerosene in homes with active tuberculosis disease in South Africa. BMC Res Notes. 2017 Nov 13; 10(1):591.
    View in: PubMed
    Score: 0,014
  43. Multidisciplinary Point-of-Care Testing in South African Primary Health Care Clinics Accelerates HIV ART Initiation but Does Not Alter Retention in Care. J Acquir Immune Defic Syndr. 2017 09 01; 76(1):65-73.
    View in: PubMed
    Score: 0,014
  44. Enterovirus genotypes among patients with severe acute respiratory illness, influenza-like illness, and asymptomatic individuals in South Africa, 2012-2014. J Med Virol. 2017 10; 89(10):1759-1767.
    View in: PubMed
    Score: 0,014
  45. Attributable Fraction of Influenza Virus Detection to Mild and Severe Respiratory Illnesses in HIV-Infected and HIV-Uninfected Patients, South Africa, 2012-2016. Emerg Infect Dis. 2017 07; 23(7):1124-1132.
    View in: PubMed
    Score: 0,014
  46. Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting. J Infect. 2017 10; 75(4):346-355.
    View in: PubMed
    Score: 0,014
  47. Enterovirus D68 and other enterovirus serotypes identified in South African patients with severe acute respiratory illness, 2009-2011. Influenza Other Respir Viruses. 2017 05; 11(3):211-219.
    View in: PubMed
    Score: 0,013
  48. HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa. J Antimicrob Chemother. 2017 01; 72(1):210-219.
    View in: PubMed
    Score: 0,013
  49. Knowledge, attitudes, and practices about influenza illness and vaccination: a cross-sectional survey in two South African communities. Influenza Other Respir Viruses. 2016 09; 10(5):421-8.
    View in: PubMed
    Score: 0,013
  50. Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB. J Antimicrob Chemother. 2016 Apr; 71(4):1037-40.
    View in: PubMed
    Score: 0,012
  51. Legionnaires' Disease in South Africa, 2012-2014. Emerg Infect Dis. 2016 Jan; 22(1):131-3.
    View in: PubMed
    Score: 0,012
  52. Latent tuberculous infection in schoolchildren and contact tracing in Matlosana, North West Province, South Africa. Int J Tuberc Lung Dis. 2015 Nov; 19(11):1290-2.
    View in: PubMed
    Score: 0,012
  53. Undiagnosed TB in adults dying at home from natural causes in a high TB burden setting: a post-mortem study. Int J Tuberc Lung Dis. 2015 Nov; 19(11):1320-5.
    View in: PubMed
    Score: 0,012
  54. Case-ascertained study of household transmission of seasonal influenza - South Africa, 2013. J Infect. 2015 Nov; 71(5):578-86.
    View in: PubMed
    Score: 0,012
  55. Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. Int J Tuberc Lung Dis. 2015 Aug; 19(8):979-85.
    View in: PubMed
    Score: 0,012
  56. Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013. PLoS One. 2015; 10(3):e0118884.
    View in: PubMed
    Score: 0,012
  57. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. Lancet. 2015 May 02; 385(9979):1738-1747.
    View in: PubMed
    Score: 0,012
  58. Epidemiology of severe acute respiratory illness (SARI) among adults and children aged =5 years in a high HIV-prevalence setting, 2009-2012. PLoS One. 2015; 10(2):e0117716.
    View in: PubMed
    Score: 0,012
  59. Influenza virus infection is associated with increased risk of death amongst patients hospitalized with confirmed pulmonary tuberculosis in South Africa, 2010-2011. BMC Infect Dis. 2015 Jan 27; 15:26.
    View in: PubMed
    Score: 0,012
  60. Epidemiology of viral-associated acute lower respiratory tract infection among children <5 years of age in a high HIV prevalence setting, South Africa, 2009-2012. Pediatr Infect Dis J. 2015 Jan; 34(1):66-72.
    View in: PubMed
    Score: 0,012
  61. Genetic diversity and molecular epidemiology of human rhinoviruses in South Africa. Influenza Other Respir Viruses. 2014 Sep; 8(5):567-73.
    View in: PubMed
    Score: 0,011
  62. Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012. Emerg Infect Dis. 2014 Jul; 20(7):1162-9.
    View in: PubMed
    Score: 0,011
  63. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis. 2014 Nov 15; 210(10):1649-57.
    View in: PubMed
    Score: 0,011
  64. Incidence of TB and HIV in prospectively followed household contacts of TB index patients in South Africa. PLoS One. 2014; 9(4):e95372.
    View in: PubMed
    Score: 0,011
  65. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis. 2013 Nov; 19(11):1766-74.
    View in: PubMed
    Score: 0,011
  66. Predictors of delay in the diagnosis and treatment of suspected tuberculosis in HIV co-infected patients in South Africa. Int J Tuberc Lung Dis. 2013 Sep; 17(9):1199-205.
    View in: PubMed
    Score: 0,011
  67. HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011. J Infect Dis. 2014 Jan 01; 209(1):56-65.
    View in: PubMed
    Score: 0,010
  68. High prevalence of pulmonary tuberculosis but low sensitivity of symptom screening among HIV-infected pregnant women in South Africa. PLoS One. 2013; 8(4):e62211.
    View in: PubMed
    Score: 0,010
  69. Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding. Int J Tuberc Lung Dis. 2012 Sep; 16(9):1252-9.
    View in: PubMed
    Score: 0,010
  70. Community-based targeted case finding for tuberculosis and HIV in household contacts of patients with tuberculosis in South Africa. Am J Respir Crit Care Med. 2012 May 15; 185(10):1110-6.
    View in: PubMed
    Score: 0,010
  71. Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis. J Clin Microbiol. 2010 Aug; 48(8):2972-4.
    View in: PubMed
    Score: 0,008
  72. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. J Acquir Immune Defic Syndr. 2009 Oct 01; 52(2):145-51.
    View in: PubMed
    Score: 0,008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.